T-ACUTE MYELOID LEUKEMIA CASE THOUGHT TO BE ASSOCIATED WITH RADIOIODINE (I¹³¹) TREATMENT

Aras, Merih Reis; Tiglioglu, Pinar; Tiglioglu, Mesut; Saglam, Bugra; Yilmaz, Fatma; Olgun, Neslihan; Maral, Senem; Ozturk, Hacer Berna Afacan; Albayrak, Murat

doi:10.1016/j.htct.2021.10.1019

Hematology, Transfusion and Cell Therapy

ISSN: 2531-1379

Hematology, Transfusion and Cell Therapy is a quarterly scientific publication of the Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), Associazione Italo-Brasiliana di Ematologia (AIBE), Eurasian Hematology Oncology Group (EHOG), and Sociedade Brasileira de Oncologia Pediátrica (SOBOPE).

Hematology, Transfusion and Cell Therapy publishes original articles, review articles and case reports covering various areas in the field of hematology and hemotherapy. The journal was previously published, until 2016, as Revista Brasileira de Hematologia e Hemoterapia.

ISSN print: 2531-1379
ISSN online: 2531-1387

Published by Elsevier Editora Ltda, Rio de Janeiro, Brazil.

Indexed in:

Web of Science, LILACS, SciELO Brazil, ESCI (Web of Science), Scopus, and PubMed/PMC

Ionizing radiation and chemotherapeutic agents can cause carcinogenic effects by causing DNA damage.A 40-year-old female patient diagnosed with thyroid papillary carcinoma in 2016 and subsequently administered 150 mCi radioiodine (I¹³¹). Leukocytosis was detected in the examinations performed due to urinary system infection. She was diagnosed t(9:22) p210 positive AML M1-2. The patient had a history of Stargardt Syndrome.Development of t-AML after radioiodine treatment is very rare.

Full text is only aviable in PDF

Indexed in:

Follow us:

Subscribe to our newsletter